Long-Term Efficacy and Safety of Ipragliflozin plus Insulin in Japanese Patients with Type 2 Diabetes (IOLITE)

被引：0
|
作者：
Ishihara, Hisamitsu
Yamaguchi, Susumu
Nakao, Ikko
Okitsu, Akira
Asahina, Seitaro
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1250-P
引用
收藏
页码：A335 / A335
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Switching from Basal Insulin to Sitagliptin in Japanese Type 2 Diabetes Patients
    Harashima, S. -I.
    Tanaka, D.
    Yamane, S.
    Ogura, M.
    Fujita, Y.
    Murata, Y.
    Seike, M.
    Koizumi, T.
    Aono, M.
    Wang, Y.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (03) : 231 - 238
  • [42] Troglitazone plus sulfonylurea combination: Long term efficacy in patients with type 2 diabetes
    Draznin, B
    Driscoll, J
    Sievers, J
    Venable, T
    Ghazzi, M
    DIABETES, 1998, 47 : A85 - A85
  • [43] Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study
    Tobe, Kazuyuki
    Maegawa, Hiroshi
    Tabuchi, Hiromi
    Nakamura, Ichiro
    Uno, Satoshi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (05) : 1262 - 1271
  • [44] Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus
    Kawamori, R.
    Kadowaki, T.
    Ishii, H.
    Iwasaki, M.
    Iwamoto, Y.
    DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 891 - 899
  • [45] Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study
    Araki, Eiichi
    Mathieu, Chantal
    Shiraiwa, Toshihiko
    Maeda, Hajime
    Ikeda, Hiroki
    Thoren, Fredrik
    Arya, Niki
    Asano, Michiko
    Iqbal, Nayyar
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1496 - 1504
  • [46] Long-term efficacy and safety of evogliptin add-on therapy to dapagliflozin plus metformin combinations in poorly controlled patients with type 2 diabetes
    Moon, J.
    Kim, H.
    Chung, C.
    Won, K.
    Han, K.
    Park, C.
    Won, J.
    Kim, D.
    Koh, G.
    Kim, E.
    Yu, J.
    Hong, E.
    Lee, C.
    Yoon, K.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S307 - S307
  • [47] Linagliptin added to sulphonylurea or α-glucosidase inhibitor therapy provides similar long-term safety and efficacy to metformin in Japanese patients with type 2 diabetes
    Inagaki, N.
    Watada, H.
    Murai, M.
    Kagimura, T.
    Emser, A.
    Gong, Y.
    Patel, S.
    Woerle, H. -J.
    DIABETOLOGIA, 2012, 55 : S350 - S350
  • [48] Long-termefficacy and safety of canagliflozin in combination with insulin in Japanese type 2 diabetes patients
    Harashima, S.
    Inagaki, N.
    Kaku, K.
    Kondo, K.
    Maruyama, N.
    Otsuka, M.
    Kawaguchi, Y.
    Watanabe, Y.
    Goda, M.
    Iijima, H.
    DIABETOLOGIA, 2017, 60 : S20 - S20
  • [49] Long-term efficacy and safety of repaglinide in comparison with glibenclamide in subjects with type 2 diabetes
    Wolffenbuttel, BHR
    Landgraf, R
    DIABETOLOGIA, 1998, 41 : A235 - A235
  • [50] Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
    Ichiro Nakamura
    Hiroshi Maegawa
    Kazuyuki Tobe
    Satoshi Uno
    Diabetes Therapy, 2021, 12 : 2801 - 2805
12345